Literature DB >> 29268128

2-Substituted 7-trifluoromethyl-thiadiazolopyrimidones as alkaline phosphatase inhibitors. Synthesis, structure activity relationship and molecular docking study.

Behzad Jafari1, Meirambek Ospanov2, Syeda Abida Ejaz3, Nazym Yelibayeva2, Shafi Ullah Khan3, Sayyeda Tayyeba Amjad3, Sayfidin Safarov4, Zharylkasyn A Abilov5, Mirgul Zh Turmukhanova5, Sergey N Kalugin5, Peter Ehlers6, Joanna Lecka7, Jean Sévigny7, Jamshed Iqbal3, Peter Langer8.   

Abstract

Alkaline Phosphatases (APs) play a key role in maintaining a ratio of phosphate to inorganic pyrophosphate (Pi/PPi) and thus regulate extracellular matrix calcification during bone formation and growth. Among different isozymes of AP, aberrant increase in the level of tissue non-specific alkaline phosphatase (TNAP) is strongly associated with vascular calcification and end-stage renal diseases. In this context, we synthesized a novel series of fluorinated pyrimidone derivatives, i.e., 2-bromo-7-trifluoromethyl-5-oxo-5H-1,3,4-thiadiazolepyrimidones. The bromine functionality was further used for derivatisation by nucleophilic aromatic substitution using amines as nucleophiles as well as by Palladium catalysed Suzuki-Miyaura reactions. The synthesized derivatives were found potent but non-selective inhibitors of both isozymes of AP. Arylated thiadiazolopyrimidones exhibited stronger inhibitory activities than 2-amino-thiadiazolopyrimidones. The binding modes and possible interactions of the most active inhibitor within the active site of the enzyme were observed by molecular docking studies.
Copyright © 2017 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Alkaline Phosphatase (AP); Cross coupling reactions; Ectonucleotidases; Suzuki-Miyaura reaction; Thiadiazolopyrimidones

Mesh:

Substances:

Year:  2017        PMID: 29268128     DOI: 10.1016/j.ejmech.2017.11.068

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  1 in total

1.  Retro Diels Alder protocol for regioselective synthesis of novel [1,2,4]triazolo[4,3-a]pyrimidin-7(1H)-ones.

Authors:  Awad I Said; Márta Palkó; Matti Haukka; Ferenc Fülöp
Journal:  RSC Adv       Date:  2020-09-14       Impact factor: 4.036

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.